July 29, 2020
Speaker:
Ron DePinho, MD
Professor and Past President of MD Anderson Cancer Center
Founder of Tvardi Therapeutics, Asylia Therapeutics and Nirogy Therapeutics
Co-Founder and Chairman of Opa Health
Follow Dr. DePinho online:
rondepinho.com
opahealth.org
LinkedIn
Twitter
MD Anderson
Topic:
Status of COVID drugs|vaccines|diagnostics and accompanying digital revolution
Click below to listen to the audio from the conference: